Showing results (351-360 of 492) with videos related to
Sort By:
Pageof 50
International Journal of Cancer|June 23, 2015
Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemiaDaniela Opel, Andrea Schnaiter, Dagmar Dodier, et al.Oncogenesis|November 30, 2017
The effects of PI3K-mediated signalling on glioblastoma cell behaviourJulia Langhans, Lukas Schneele, Nancy Trenkler, et al.Oncology Letters|October 23, 2018
Viability of glioblastoma stem cells is effectively reduced by diisothiocyanate-derived mercapturic acidsKamila Cwiklowska, Mike-Andrew Westhoff, Simon Freisinger, et al.Scientific Reports|May 6, 2020
The limitations of targeting MEK signalling in Glioblastoma therapyKarthika D Selvasaravanan, Nicole Wiederspohn, Amina Hadzalic, et al.Plos One|June 30, 2015
A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma TherapyStephanie Ströbele, Matthias Schneider, Lukas Schneele, et al.Expert Opinion on Drug Discovery|August 23, 2022
Unblinding the watchmaker: cancer treatment and drug design in the face of evolutionary pressureSophia Konig, Hannah Strobel, Michael Grunert, et al.Frontiers in Immunology|March 23, 2017
The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector CellsKyra Fischer, Sara Tognarelli, Stefanie Roesler, et al.Anti-Cancer Drugs|June 9, 2015
Suberoylanilide hydroxamic acid synergistically enhances the antitumor activity of etoposide in Ewing sarcoma cell linesRebekka Unland, Dagmar Clemens, Ulrike Heinicke, et al.Archives of Disease in Childhood|July 2, 2011
Long term survival in children with acute leukaemia and complications requiring mechanical ventilationDaniel Steinbach, Bernhard Wilhelm, Hans-Rudolf Kiermaier, et al.Journal of Neuro-Oncology|December 20, 2014
Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effectGeorg Karpel-Massler, Richard Eric Kast, Mike-Andrew Westhoff, et al.Pageof 50